COMPANY
Amgen Europe B.V.
Amgen Europe B.V.: marketing authorisation holder for Carfilzomib, Etelcalcetide, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Carfilzomib | Kyprolis (EMEA/H/C/003790), Authorised Regulator EMA |
|---|---|
| Etelcalcetide | Parsabiv (EMEA/H/C/003995), Authorised Regulator EMA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.